CrowdfundedWealth

Advantage Advisers Xanthus Fund Tender: $691M, Ends Dec 15, 2026

ResearchBy Jorge18 min read24 SEC filings cited

Some links pay us a referral fee; each one says so. Disclosure

Quick answer

Advantage Advisers Xanthus Fund, L.L.C. (SEC CIK 1076673), a technology-focused long/short equity fund run by Alkeon Capital Management under Oppenheimer's adviser, filed a Schedule TO-I on November 17, 2026 (accession 0001104659-26-129122). It offers to buy up to $691.45 million of interests, 25.0% of the $2,765,810,054.40 of capital outstanding on October 31, 2026 (our arithmetic). The offer ends at 12:00 midnight Eastern Time on December 15, 2026; the price is the net asset value on December 31, 2026, with at least 95% of a full tender paid by January 14, 2027 and the rest after the 2026 audit. In eight earlier offers, holders asked to sell between 13.5% and 26.7% of the amount offered, and every request was paid in full.

Key takeaways

  • The cap is 25.0% of capital, but requests have been far smaller. The May 2026 offer, for up to $834.70 million, drew $112,316,790.19, or 13.5% of the cap and 3.4% of the $3,338,782,353.86 of capital then outstanding (our arithmetic). The highest request of the eight was $149,829,804.44 in the offer that ended June 13, 2024. No offer has been prorated.
  • Capital fell between offers. Form N-PORT shows net assets of $3,384,552,587 on June 30, 2026 and $2,975,113,743 on September 30, 2026; the offer papers give $2,765,810,054.40 on October 31, 2026, 18.3% below June 30 (our arithmetic, including subscriptions and withdrawals). N-PORT reports monthly returns of negative 8.52% for July 2026, negative 2.51% for August and 0.77% for September.
  • The price is set after you decide. You must act by December 15, 2026, and the price is the December 31, 2026 NAV, so a full tender is valued about two weeks after the deadline. The fund may cancel or postpone the offer if there is a “material decrease in the net asset value of the Fund from the net asset value of the Fund as of commencement of the Offer”.
  • Cost has three layers: a 1.35% administration fee and a 0.40% advisory fee on members' capital, an incentive allocation of 20% of net profits above each member's Loss Recovery Account, and a placement fee of up to 3%. The expense ratio before incentive was 3.56% in 2025, and the incentive allocation took another 2.20% of average capital that year.
  • A full tender triggers the incentive allocation at the repurchase date. The first-half 2026 report says $84,640,668 would have been credited on six months of profits, against $1,856,525 actually credited, because the charge is made at year end.
  • The fund has net outflows: contributions of $44,004,956 against withdrawals of $297,845,267 in 2025, and $35,390,905 against $114,173,315 in the first half of 2026. Capital grew from $1.8 billion at the end of 2022 to $3.4 billion in June 2026 on returns, not on new money.

Filing alert · free

An email when Advantage Advisers Xanthus Fund files with the SEC

An email the day Advantage Advisers Xanthus Fund files something new, with the link to the document on the SEC site.

CSV · 143 rows

Advantage Advisers Xanthus Fund: the December 2026 tender offer, eight earlier offers, capital, returns, fees and portfolio

143 rows from the November 17, 2026 Schedule TO-I and its Offer to Purchase, eight earlier offers with their final amendments, the annual and semiannual reports (Form N-CSR and N-CSRS) and four Form N-PORT filings: terms, capital, tenders, returns, fees, flows and portfolio structure.

What the fund is, and what this page adds

Advantage Advisers Xanthus Fund is a Delaware limited liability company, organized in January 1999, that registered as a closed-end fund. Its objective is “to achieve maximum capital appreciation”, pursued with long and short positions “primarily in equity securities, purchased options and total return swaps”, with technology-related growth companies as “an important part of the universe”. The investment adviser is Advantage Advisers Multi-Manager, L.L.C., a subsidiary of Oppenheimer Asset Management Inc.; Alkeon Capital Management L.L.C. is the sub-investment adviser that runs the portfolio. The fund has a six-member Board of Managers, one of whom is an interested person under the 1940 Act.

We have no earlier page on this fund. It is a different kind of vehicle from the interval funds and private-equity feeder funds we cover: you cannot sell back at any time, and the board decides whether to offer at all. For how tender-offer funds work in general, see what a tender offer fund is and how proration works. Alkeon also advises a separate interval fund that we cover, ACAP Strategic Fund, which has its own 25% offer closing December 17, 2026; the two are different registrants with different holders. The Xanthus report says its board compared fees with “another registered fund with an investment program similar to that of the Company”, without naming it.

The offer filed November 17, 2026

TermWhat the Schedule TO-I and Offer to Purchase say
FiledNovember 17, 2026, Schedule TO-I, accession 0001104659-26-129122
AmountUp to $691.45 million of interests, 25.0% of $2,765,810,054.40 outstanding on October 31, 2026 (our arithmetic)
Deadline12:00 midnight Eastern Time, Tuesday, December 15, 2026, unless extended
PriceNet asset value on December 31, 2026 (the Valuation Date); the fund will use the audited figure for the final amount
Full tender: paymentAt least 95% of unaudited NAV, less any incentive allocation, in cash and/or marketable securities no later than January 14, 2027; the balance by a non-transferable Note paid after the 2026 audit, which the fund expects by the end of February 2027
Partial tender: payment100% of estimated unaudited NAV of the part tendered, by January 14, 2027; you must keep the minimum balance plus any tentative incentive allocation
If oversubscribedAccept extra interests allowed by Rule 13e-4(f)(1)(ii), or amend and extend; the Schedule TO-I also says tenders are accepted pro rata by NAV
WithdrawalUntil midnight on December 15, 2026, and again after January 14, 2027 if the fund has not accepted the tender
Where to sendLetter of Transmittal to BNY (OPCO Investor Services) by mail, fax or e-mail, then call BNY to confirm receipt before the deadline
Fee to tenderNone stated in the offer

Four details matter. First, the price is not known when you decide: the offer says the value of interests “will likely change between October 31, 2026” and the December 31, 2026 valuation date. Second, the offer is not a promise: among the triggers that let the fund cancel, amend or postpone is a “material decrease in the net asset value of the Fund from the net asset value of the Fund as of commencement of the Offer” (Offer to Purchase, Section 7). Capital outstanding on October 31, 2026 was 7.0% below the $2,975,113,743 of net assets on September 30, 2026 (our arithmetic, flows included). Third, interests “may be presented to the Fund for purchase only by tendering them during one of the Fund's announced tender offers”, and the fund's report says no member “has the right to require the Company to redeem any portion of its Interest”. Fourth, the fund can pay in marketable securities, though it says it expects to pay entirely in cash “except in the unlikely event” the board decides otherwise.

The cash is not borrowed yet. The fund says it has not decided to borrow, but may use its margin facility with Morgan Stanley, the prime broker, and would repay it from new subscriptions or sales of portfolio assets. New money still arrives: the fund expects to accept subscriptions on December 1, 2026 and monthly after that.

Nine offers: what holders asked for

The fund offers twice a year, effective at the end of June and the end of December. Each offer is sized at 25% of capital outstanding at the last month-end before it (our arithmetic). Results are from the final amendments to Schedule TO-I.

Offer (expired)Capital outstanding when offeredUp toTendered and paidShare of capShare of capital
Dec 15, 2022$1,828,438,566.79 (Oct 31, 2022)$457.1M$94,665,045.7720.7%5.2%
Jun 12, 2023$2,085,504,393.71 (Apr 30, 2023)$521.4M$85,741,103.1916.4%4.1%
Dec 15, 2023$1,966,692,095.92 (Oct 31, 2023)$491.67M$131,162,936.4326.7%6.7%
Jun 13, 2024$2,418,372,011.48 (Apr 30, 2024)$604.59M$149,829,804.4424.8%6.2%
Dec 13, 2024$2,555,902,349.36 (Oct 31, 2024)$638.98M$114,285,162.9317.9%4.5%
Jun 12, 2025$2,517,608,668.67 (Apr 30, 2025)$629.40M$101,123,708.4916.1%4.0%
Dec 15, 2025$3,281,570,022.82 (Oct 31, 2025)$820.39M$132,599,429.9316.2%4.0%
Jun 12, 2026$3,338,782,353.86 (Apr 30, 2026)$834.70M$112,316,790.1913.5%3.4%
Dec 15, 2026 (open)$2,765,810,054.40 (Oct 31, 2026)$691.45MNot yet reported

In every completed offer the final amendment says all interests validly tendered “were accepted for purchase and paid by the Fund”. With requests never above 26.7% of the cap, the fund has never had to choose between proration, extra purchases and an enlarged offer, and the filings give no evidence of how it would. The cap in this offer is the first to fall below its predecessor since June 2025, because capital is lower, not because the 25% rule changed (our arithmetic).

The tender results match the fund's own accounts: the June and December 2025 tenders add to $233,723,138 (our arithmetic), the figure in the 2025 statement of changes in members' capital for member withdrawals. The June and December 2024 tenders likewise add to $264,114,967.

Capital and returns: a fund that moves with one sector

PeriodMembers' capital at endNet return (after incentive allocation)Gross returnExpense ratio, before incentive
2020$3,774,356,00056.74%70.93%3.37%
2021$3,312,937,000negative 15.51%negative 15.51%3.21%
2022$1,815,273,000negative 40.69%negative 40.69%4.09%
2023$2,117,624,00027.95%27.95%4.08%
2024$2,467,004,00027.95%27.95%3.86%
2025$3,030,770,00031.08%33.38%3.56%
First half 2026 (not annualized)$3,384,553,00011.32%14.15%3.91% (annualized)

Returns exclude any placement fee. The 2023 and 2024 returns are both printed as 27.95% in the fund's reports. Net returns for 2021 to 2025 compound to 7.5% over five years (our arithmetic), so a holder from January 1, 2021 was up about 7.5% at the end of 2025 before the 2026 swings. A 40.69% fall needs a 68.6% gain to recover (our arithmetic).

Form N-PORT gives monthly returns for the last four quarters:

QuarterFirst monthSecond monthThird month
October to December 20251.50%negative 0.89%negative 0.72%
January to March 20262.29%1.64%negative 6.70%
April to June 202610.65%0.94%2.74%
July to September 2026negative 8.52%negative 2.51%0.77%

July to September 2026 compounds to negative 10.1% (our arithmetic). We found no filing that reports returns after September 2026; the capital figure for October 31, 2026 is the only later data point, and the filings do not split its fall into market results and flows.

What the fund holds, and how much borrowed exposure it carries

At June 30, 2026 the fund's long common stock was 108.81% of members' capital ($3,682,658,057 at fair value), purchased options 12.70%, and securities sold short negative 50.36% ($1,704,321,933). It also held total return swaps, with unrealized gains and losses on both sides. Total assets were $5,448,760,645 against members' capital of $3,384,552,587, 1.61 times (our arithmetic), because the short sales and swaps sit alongside the long book; due from brokers was $917,787,403, all restricted cash. The largest disclosed position, Taiwan Semiconductor Manufacturing's ADR at $205,851,295, was 6.08% of capital. The fund calls itself diversified under the 1940 Act but warns that it “may be concentrated in one or more industry sectors”.

The fund is not a hedge fund of funds: it holds stocks, options and swaps directly. Its results therefore track its stock picks, which lean to technology and growth: the fund fell 40.69% in 2022 and gained 31.08% in 2025.

What it costs

LayerRate or amountSource and note
Administration and investor services1.35% a year of members' capitalPaid monthly to Multi-Manager; $21,452,596 in the first half of 2026
Investment advisory0.40% a year of members' capitalOf which 0.30% goes to Alkeon; $6,356,325 in the first half of 2026
Incentive allocation20% of net profits above the member's Loss Recovery AccountCharged at fiscal year end and when a member's entire interest is repurchased
Placement feeUp to 3% (up to 3.1% of the amount invested)Charged by Oppenheimer as placement agent, in its discretion, on purchases; reduces the amount invested
Prime broker fees$16,924,543 in the first half of 2026Operating expense of the fund
Dividends on short positions$14,603,050 in the first half of 2026Operating expense of the fund
Distribution or servicing feesNoneThe board noted the fund “does not bear distribution or shareholder servicing fees”

Total operating expenses for the first half of 2026 were $62,966,786 against investment income of $31,032,731, a net investment loss of $31,934,055. The incentive allocation is separate: $64,122,129 was credited in 2025, 2.20% of average capital. At June 30, 2026 the fund disclosed that the allocation “that would have been credited” on first-half profits was $84,640,668, about 2.5% of members' capital (our arithmetic), but only $1,856,525 had actually been credited because the charge is made at year end.

Worked example (our arithmetic): on $100,000 the administration and advisory fees are 1.75%, or $1,750 a year. With the 2025 expense ratio of 3.56% the cost before incentive was $3,560, and at the 2025 incentive ratio of 2.20% a further $2,200, for $5,760 in a year when the net return was 31.08%. A purchase through Oppenheimer could carry a placement fee of up to $3,100 on $100,000. The 2025 incentive ratio is an average across members; each member's own charge depends on their Loss Recovery Account.

Who can hold it, and who does

The fund sells interests “in transactions not involving any public offering conducted pursuant to Rule 506 of Regulation D”, so it is a private placement that happens to be registered. The Offer to Purchase says payment notes are held in the member's “brokerage account through which the Member invested”, the cover letter tells members to call “your Financial Advisor”, and Oppenheimer acts as placement agent. Individuals therefore hold it through brokerage accounts. What we could not find on EDGAR is the minimum investment or the investor test: those sit in the Confidential Memorandum given to investors, which is not a public filing. The offer refers to “the current minimum initial investment requirement imposed by the Fund” without stating it, and the filings do not give a count of holders. If you hold it, your statement and that memorandum are the place to look.

What a holder can do with this

  • Decide by midnight on December 15, 2026. You can withdraw a tender until then. Your adviser or custodian may need your instruction earlier; ask. After the Letter of Transmittal goes to BNY, call to confirm receipt, as the offer requires.
  • Remember you are priced on December 31, 2026, not today. Between October 31, 2026 and the valuation date the value will move; the fund's estimated NAV is available from BNY weekly and daily in the last five business days of the offer.
  • Ask what your full tender would cost. A full tender triggers the 20% incentive allocation at the repurchase date. Ask your adviser for your Loss Recovery Account balance and your cost basis.
  • Plan for the 5% holdback. On a full tender at least 95% is paid by January 14, 2027; the rest comes after the audit expected by the end of February 2027. On a $1,000,000 position that is $950,000 first and up to $50,000 later (our arithmetic), less the incentive allocation.
  • Check tax with a tax adviser. The offer says a member whose interest is purchased is treated as receiving a distribution and generally recognizes gain only to the extent cash received exceeds its adjusted tax basis, and that a full tender may produce a loss.
  • Note the pattern. The fund has offered every June and December since December 1999 (its own account of its history). If the pattern holds the next offer would be filed in May 2027; that is a pattern in the filing dates, not a promise. The fund's agreement also says it will be dissolved if a member's written request to tender its entire interest has not been purchased within two years.

FAQ

All figures are from the SEC filings of Advantage Advisers Xanthus Fund, L.L.C. (CIK 1076673) read on EDGAR on November 20, 2026: the Schedule TO-I filed November 17, 2026 with its exhibits (accession 0001104659-26-129122); the earlier Schedules TO-I (0000902664-22-004939, 0001104659-23-060587, 0001104659-23-119425, 0001104659-24-062445, 0001104659-24-119649, 0001104659-25-049079, 0001104659-25-113058, 0001104659-26-062384) and their final amendments (0001104659-23-058490, 0001104659-23-081485, 0001104659-24-029413, 0001104659-24-086263, 0001104659-25-009193, 0001104659-25-102060, 0001104659-26-012104, 0001104659-26-084070); the reports on Form N-CSR (0001104659-25-021249, 0001104659-26-024070) and Form N-CSRS (0001104659-26-104659); and Form N-PORT filings (0001193125-26-053646, 0001193125-26-207983, 0001193125-26-355127, 0001193125-26-453203). This is analysis of public documents, not investment, legal or tax advice.

Affiliate Disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This does not affect our ratings. Learn more.